speb/financial-data huggingface dataset:
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1295000000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 164100000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 6038600000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 5288500000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 5905400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 117510204.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -4.90
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 870600000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 630400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 630400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 117510204.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -4.90
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -575800000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — EBIT: -235400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 395000000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 5034800000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 502900000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 502900000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 65200000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Income: -575800000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -575800000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -641000000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -575800000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -575800000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -641000000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -502900000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -502900000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 395000000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -575800000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: -253700000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 5905400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 18300000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 3051300000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -738300000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 870600000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 630400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1236400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1236400000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: -97300000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.13
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 6159100000.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
SAGCEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SAGCEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 18836700000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 6195800000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 25733200000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 7869600000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 6061000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 6061000000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2259400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2259400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -19964800000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -19964800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 8835100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 8835100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -166300000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -166300000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Amortization: 38200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 38200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 522000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 522000000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 114509804.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 7.65
SAGCEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 704900000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 8358200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 8358200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -4233100000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -4233100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 363600000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 363600000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 261400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 261400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 35200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 35200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 35200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 35200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 0.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 0.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 35200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 35200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -391100000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -674600000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 267700000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: 202000000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -257300000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -785900000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -669700000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 261400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 261400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 16929200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 16929200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 876400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1157700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1157700000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 6411800000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1521000000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 7599300000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 7599300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 89200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 89200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 4422100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 4422100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 4511300000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4511300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 12058000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 12058000000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 83900000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 83900000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 2358300000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 2396500000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 2396500000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 662600000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 2358300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 662600000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 114509804.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 7.65
SAGCEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -110700000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 876000000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 2700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 2700000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — EBIT: 432500000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — EBIT: 264700000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — EBITDA: 2829000000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 927300000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 35200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 1296200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 212200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 212200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -2077500000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -13200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -67800000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 273700000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Goodwill: 416200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 416200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1195600000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1195600000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 2425700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 2425700000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 52212900000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 52212900000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 19321400000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 6348600000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 13200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 13200000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 1663100000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 530900000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1663100000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 530900000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Interest Income: 105200000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 105200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1843500000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 65100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 3127100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 3127100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 33649100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 33649100000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -4121500000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 522000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 522000000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 876400000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 3972300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 4684800000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 4684800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 274400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 274400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 12297800000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 12297800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12572200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12572200000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 3972300000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1600300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 114200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 114200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 34437100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 34437100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 1680000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1680000000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Minority Interests: -103400000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -124500000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 876400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 16684700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 16684700000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 9700000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Income: -110700000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Income: 876000000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -110700000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 876000000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -7300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1000500000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -110700000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 876000000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -110700000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 876000000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -1230600000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -7300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1000500000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1864300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -530900000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -24900000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 2365700000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 2372000000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1864300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -530900000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 32248100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 32248100000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 72100000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -6300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 15733600000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 15733600000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Non Current Accrued Expenses: 15300000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 15300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 2262900000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 2262900000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 345800000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 345800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 191700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 191700000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 1520400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 1520400000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2686500000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 927300000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Normalized Income: -196200000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 876000000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 2155600000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Operating Income: 484700000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 152800000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 25733200000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 7869600000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 130707548.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 130707548.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 719000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 719000000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 436400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 436400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 16667800000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 16667800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 779400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 779400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 1255300000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 1255300000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1836900000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1067500000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1067500000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1042300000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1042300000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 29300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 111900000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 9738600000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 3587900000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Payable: 249800000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 249800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 3575100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 3575100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 396100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 396100000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 1403100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1403100000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Other Special Charges: -98900000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Payables: 6313500000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 6313500000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 83900000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 83900000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 730000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 730000000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Pretax Income: -1230600000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -266200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 9000000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1056600000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 921200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 921200000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 6411800000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1521000000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 2396500000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 662600000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 28800000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 28800000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1600300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 970200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 970200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 3927700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3927700000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 1031700000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 72100000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 5635600000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1555800000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 5909300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1555800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 130707548.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 130707548.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Special Income Charges: 129300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 16929200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 16929200000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 15733600000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 15733600000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 57000000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Tax Provision: -1223300000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -1266700000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 68100000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 68100000.00
SAGCEM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: 800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 45052700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 45052700000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 29227000000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 29227000000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 17083500000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 17083500000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 18609200000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 18609200000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Total Expenses: 25248500000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 7716800000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 26443500000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 26443500000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 37453400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 37453400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14385500000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14385500000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 306400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 142500000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 142500000.00
SAGCEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Tradeand Other Payables Non Current: 19300000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 19300000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Work In Process: 738400000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 738400000.00
SAGCEM.NS balance_sheet (annual, 2026-03-31) — Working Capital: -4458700000.00
SAGCEM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: -4458700000.00
SAGCEM.NS income_statement (annual, 2026-03-31) — Write Off: -30400000.00
SAGE.V income_statement (annual, 2023-03-31) — +Operating Expense: 4132818.00
SAGE.V income_statement (annual, 2023-03-31) — +Total Revenue: 0.00
SAGE.V income_statement (annual, 2023-03-31) — Basic Average Shares: 41152953.00
SAGE.V income_statement (annual, 2023-03-31) — Basic EPS: -0.10
SAGE.V cash_flow (annual, 2023-03-31) — Beginning Cash Position: 621923.00
SAGE.V cash_flow (annual, 2023-03-31) — Capital Expenditure: -865191.00
SAGE.V balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 89634.00
SAGE.V balance_sheet (annual, 2023-03-31) — Capital Stock: 5591885.00
SAGE.V balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1517363.00
SAGE.V balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1517363.00
SAGE.V balance_sheet (annual, 2023-03-31) — Cash Financial: 1517363.00
SAGE.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 4286985.00
SAGE.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -865191.00
SAGE.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -2526354.00
SAGE.V cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: 783207.00
SAGE.V cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: -485885.00
SAGE.V cash_flow (annual, 2023-03-31) — Change In Receivables: -69636.00
SAGE.V cash_flow (annual, 2023-03-31) — Change In Working Capital: 227686.00
SAGE.V cash_flow (annual, 2023-03-31) — Changes In Cash: 895440.00
SAGE.V balance_sheet (annual, 2023-03-31) — Common Stock: 5591885.00
SAGE.V balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2371630.00
SAGE.V cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
SAGE.V income_statement (annual, 2023-03-31) — Cost Of Revenue: 24720.00
SAGE.V balance_sheet (annual, 2023-03-31) — Current Assets: 2084886.00
SAGE.V balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 35221.00
SAGE.V balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 35221.00
SAGE.V balance_sheet (annual, 2023-03-31) — Current Liabilities: 904684.00
SAGE.V cash_flow (annual, 2023-03-31) — Depreciation: 24720.00
SAGE.V cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 24720.00
SAGE.V cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 24720.00
SAGE.V income_statement (annual, 2023-03-31) — Diluted Average Shares: 41152953.00
SAGE.V income_statement (annual, 2023-03-31) — Diluted EPS: -0.10
SAGE.V income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -4117553.00
SAGE.V balance_sheet (annual, 2023-03-31) — Duefrom Related Parties Current: 11073.00
SAGE.V income_statement (annual, 2023-03-31) — EBIT: -4110760.00
SAGE.V income_statement (annual, 2023-03-31) — EBITDA: -4086040.00
SAGE.V cash_flow (annual, 2023-03-31) — End Cash Position: 1517363.00
SAGE.V cash_flow (annual, 2023-03-31) — Financing Cash Flow: 4286985.00
SAGE.V cash_flow (annual, 2023-03-31) — Free Cash Flow: -3391545.00
SAGE.V income_statement (annual, 2023-03-31) — Gain On Sale Of Security: -650.00
SAGE.V income_statement (annual, 2023-03-31) — General And Administrative Expense: 2808249.00
SAGE.V balance_sheet (annual, 2023-03-31) — Gross PPE: 1245841.00
SAGE.V income_statement (annual, 2023-03-31) — Gross Profit: -24720.00
SAGE.V income_statement (annual, 2023-03-31) — Insurance And Claims: 0.00
SAGE.V income_statement (annual, 2023-03-31) — Interest Expense: 6793.00
SAGE.V income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 6793.00
SAGE.V income_statement (annual, 2023-03-31) — Interest Income: 39628.00
SAGE.V income_statement (annual, 2023-03-31) — Interest Income Non Operating: 39628.00
SAGE.V balance_sheet (annual, 2023-03-31) — Invested Capital: 2371630.00
SAGE.V cash_flow (annual, 2023-03-31) — Investing Cash Flow: -865191.00
SAGE.V cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
SAGE.V balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 54413.00
SAGE.V balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 54413.00
SAGE.V cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -28400.00
SAGE.V cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
SAGE.V income_statement (annual, 2023-03-31) — Net Income: -4117553.00
SAGE.V income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -4117553.00
SAGE.V income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -4117553.00
SAGE.V income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -4117553.00
SAGE.V income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -4117553.00
SAGE.V cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -4117553.00
SAGE.V income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -4117553.00
SAGE.V income_statement (annual, 2023-03-31) — Net Interest Income: 32835.00
SAGE.V cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -28400.00
SAGE.V cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -28400.00
SAGE.V income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 32835.00
SAGE.V balance_sheet (annual, 2023-03-31) — Net PPE: 1245841.00
SAGE.V cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -865191.00
SAGE.V balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2371630.00
SAGE.V income_statement (annual, 2023-03-31) — Normalized EBITDA: -4085390.00
SAGE.V income_statement (annual, 2023-03-31) — Normalized Income: -4116903.00
SAGE.V cash_flow (annual, 2023-03-31) — Operating Cash Flow: -2526354.00
SAGE.V income_statement (annual, 2023-03-31) — Operating Income: -4157538.00
SAGE.V income_statement (annual, 2023-03-31) — Operating Revenue: 0.00
SAGE.V balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 48945400.00
SAGE.V balance_sheet (annual, 2023-03-31) — Other Equity Interest: 1281000.00
SAGE.V income_statement (annual, 2023-03-31) — Other Gand A: 1419426.00
SAGE.V income_statement (annual, 2023-03-31) — Other Income Expense: 7150.00
SAGE.V cash_flow (annual, 2023-03-31) — Other Non Cash Items: 6793.00
SAGE.V income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 7800.00
SAGE.V income_statement (annual, 2023-03-31) — Other Operating Expenses: 1031792.00
SAGE.V balance_sheet (annual, 2023-03-31) — Other Properties: 1245841.00
SAGE.V balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 869463.00
SAGE.V balance_sheet (annual, 2023-03-31) — Prepaid Assets: 494018.00
SAGE.V income_statement (annual, 2023-03-31) — Pretax Income: -4117553.00
SAGE.V cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 4315385.00
SAGE.V balance_sheet (annual, 2023-03-31) — Receivables: 73505.00
SAGE.V income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 24720.00
SAGE.V income_statement (annual, 2023-03-31) — Reconciled Depreciation: 24720.00
SAGE.V income_statement (annual, 2023-03-31) — Rent And Landing Fees: 56823.00
SAGE.V income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 56823.00
SAGE.V cash_flow (annual, 2023-03-31) — Repayment Of Debt: -28400.00
SAGE.V balance_sheet (annual, 2023-03-31) — Retained Earnings: -4501255.00
SAGE.V income_statement (annual, 2023-03-31) — Salaries And Wages: 1332000.00
SAGE.V income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 292777.00
SAGE.V income_statement (annual, 2023-03-31) — Selling General And Administration: 3101026.00
SAGE.V balance_sheet (annual, 2023-03-31) — Share Issued: 48945400.00
SAGE.V income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
SAGE.V cash_flow (annual, 2023-03-31) — Stock Based Compensation: 1332000.00
SAGE.V balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2371630.00
SAGE.V balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2371630.00
SAGE.V income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
SAGE.V income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
SAGE.V balance_sheet (annual, 2023-03-31) — Taxes Receivable: 62432.00
SAGE.V balance_sheet (annual, 2023-03-31) — Total Assets: 3330727.00
SAGE.V balance_sheet (annual, 2023-03-31) — Total Capitalization: 2371630.00
SAGE.V balance_sheet (annual, 2023-03-31) — Total Debt: 89634.00
SAGE.V balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2371630.00
SAGE.V income_statement (annual, 2023-03-31) — Total Expenses: 4157538.00
SAGE.V balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 959097.00
SAGE.V balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1245841.00
SAGE.V balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 54413.00
SAGE.V income_statement (annual, 2023-03-31) — Total Unusual Items: -650.00
SAGE.V income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -650.00
SAGE.V balance_sheet (annual, 2023-03-31) — Working Capital: 1180202.00
SAGE.V income_statement (annual, 2024-03-31) — +Operating Expense: 3885866.00
SAGE.V income_statement (annual, 2024-03-31) — +Total Revenue: 0.00
SAGE.V balance_sheet (annual, 2024-03-31) — Accounts Payable: 1468002.00
SAGE.V balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: 0.00
SAGE.V cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 0.00
SAGE.V income_statement (annual, 2024-03-31) — Basic Average Shares: 52513336.00
SAGE.V income_statement (annual, 2024-03-31) — Basic EPS: -0.07
SAGE.V cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1517363.00
SAGE.V cash_flow (annual, 2024-03-31) — Capital Expenditure: -190258.00
SAGE.V balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 54412.00
SAGE.V balance_sheet (annual, 2024-03-31) — Capital Stock: 6829123.00
SAGE.V balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 108007.00
SAGE.V balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 108007.00
SAGE.V balance_sheet (annual, 2024-03-31) — Cash Financial: 108007.00
SAGE.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 1490597.00
SAGE.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -190258.00
SAGE.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: -2709695.00
SAGE.V cash_flow (annual, 2024-03-31) — Change In Other Working Capital: -11530.00
SAGE.V cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 609412.00
SAGE.V cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: 298104.00
SAGE.V cash_flow (annual, 2024-03-31) — Change In Receivables: 39278.00
SAGE.V cash_flow (annual, 2024-03-31) — Change In Working Capital: 935264.00
SAGE.V cash_flow (annual, 2024-03-31) — Changes In Cash: -1409356.00
SAGE.V balance_sheet (annual, 2024-03-31) — Common Stock: 6829123.00
SAGE.V balance_sheet (annual, 2024-03-31) — Common Stock Equity: 226282.00
SAGE.V cash_flow (annual, 2024-03-31) — Common Stock Issuance: 1407962.00
SAGE.V income_statement (annual, 2024-03-31) — Cost Of Revenue: 37081.00
SAGE.V balance_sheet (annual, 2024-03-31) — Current Assets: 349678.00
SAGE.V balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 40080.00
SAGE.V balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 40080.00
SAGE.V balance_sheet (annual, 2024-03-31) — Current Liabilities: 1508082.00
SAGE.V cash_flow (annual, 2024-03-31) — Depreciation: 37081.00
SAGE.V cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 37081.00
SAGE.V cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 37081.00
SAGE.V income_statement (annual, 2024-03-31) — Diluted Average Shares: 52513336.00
SAGE.V income_statement (annual, 2024-03-31) — Diluted EPS: -0.07
SAGE.V income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -3908492.00
SAGE.V balance_sheet (annual, 2024-03-31) — Duefrom Related Parties Current: 22603.00
SAGE.V balance_sheet (annual, 2024-03-31) — Dueto Related Parties Current: 0.00
SAGE.V income_statement (annual, 2024-03-31) — EBIT: -3901114.00
SAGE.V income_statement (annual, 2024-03-31) — EBITDA: -3864033.00
SAGE.V cash_flow (annual, 2024-03-31) — End Cash Position: 108007.00
SAGE.V cash_flow (annual, 2024-03-31) — Financing Cash Flow: 1490597.00
SAGE.V cash_flow (annual, 2024-03-31) — Free Cash Flow: -2899953.00
SAGE.V income_statement (annual, 2024-03-31) — Gain On Sale Of Security: -1507.00
SAGE.V income_statement (annual, 2024-03-31) — General And Administrative Expense: 1490624.00
SAGE.V balance_sheet (annual, 2024-03-31) — Gross PPE: 1399018.00
SAGE.V income_statement (annual, 2024-03-31) — Gross Profit: -37081.00
SAGE.V income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
SAGE.V income_statement (annual, 2024-03-31) — Insurance And Claims: 69950.00
SAGE.V income_statement (annual, 2024-03-31) — Interest Expense: 7378.00
SAGE.V income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 7378.00
SAGE.V income_statement (annual, 2024-03-31) — Interest Income: 495.00
SAGE.V income_statement (annual, 2024-03-31) — Interest Income Non Operating: 495.00
SAGE.V balance_sheet (annual, 2024-03-31) — Invested Capital: 226282.00
SAGE.V cash_flow (annual, 2024-03-31) — Investing Cash Flow: -190258.00
SAGE.V cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 1407962.00
SAGE.V balance_sheet (annual, 2024-03-31) — Leases: 0.00
SAGE.V balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 14332.00
SAGE.V balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 14332.00
SAGE.V cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -42600.00
SAGE.V balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 0.00
SAGE.V cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 1407962.00
SAGE.V income_statement (annual, 2024-03-31) — Net Income: -3908492.00
SAGE.V income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -3908492.00
SAGE.V income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -3908492.00
SAGE.V income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -3908492.00
SAGE.V income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -3908492.00
SAGE.V cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -3908492.00
SAGE.V income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -3908492.00
SAGE.V income_statement (annual, 2024-03-31) — Net Interest Income: -6883.00
SAGE.V cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -42600.00
SAGE.V cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -42600.00
SAGE.V income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -6883.00
SAGE.V balance_sheet (annual, 2024-03-31) — Net PPE: 1399018.00
SAGE.V cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -190258.00
SAGE.V balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 226282.00
SAGE.V income_statement (annual, 2024-03-31) — Normalized EBITDA: -3873399.00
SAGE.V income_statement (annual, 2024-03-31) — Normalized Income: -3917858.00
SAGE.V cash_flow (annual, 2024-03-31) — Operating Cash Flow: -2709695.00
SAGE.V cash_flow (annual, 2024-03-31) — Operating Gains Losses: -10873.00
SAGE.V income_statement (annual, 2024-03-31) — Operating Income: -3922947.00
SAGE.V income_statement (annual, 2024-03-31) — Operating Revenue: 0.00
SAGE.V balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 54141193.00
SAGE.V balance_sheet (annual, 2024-03-31) — Other Equity Interest: 1806906.00
SAGE.V income_statement (annual, 2024-03-31) — Other Gand A: 1135458.00
SAGE.V income_statement (annual, 2024-03-31) — Other Income Expense: 21338.00
SAGE.V cash_flow (annual, 2024-03-31) — Other Non Cash Items: 7378.00
SAGE.V income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 11972.00
SAGE.V income_statement (annual, 2024-03-31) — Other Operating Expenses: 753046.00
SAGE.V balance_sheet (annual, 2024-03-31) — Other Properties: 1399018.00
SAGE.V income_statement (annual, 2024-03-31) — Other Special Charges: -10873.00
SAGE.V balance_sheet (annual, 2024-03-31) — Payables: 1468002.00
SAGE.V balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 1468002.00
SAGE.V balance_sheet (annual, 2024-03-31) — Prepaid Assets: 195914.00
SAGE.V income_statement (annual, 2024-03-31) — Pretax Income: -3908492.00
SAGE.V cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 125235.00
SAGE.V cash_flow (annual, 2024-03-31) — Purchase Of PPE: -190258.00
SAGE.V balance_sheet (annual, 2024-03-31) — Receivables: 45757.00
SAGE.V income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 37081.00
SAGE.V income_statement (annual, 2024-03-31) — Reconciled Depreciation: 37081.00
SAGE.V income_statement (annual, 2024-03-31) — Rent And Landing Fees: 55269.00
SAGE.V income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 55269.00
SAGE.V cash_flow (annual, 2024-03-31) — Repayment Of Debt: -42600.00
SAGE.V balance_sheet (annual, 2024-03-31) — Retained Earnings: -8409747.00
SAGE.V income_statement (annual, 2024-03-31) — Salaries And Wages: 229947.00
SAGE.V income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1642196.00
SAGE.V income_statement (annual, 2024-03-31) — Selling General And Administration: 3132820.00
SAGE.V balance_sheet (annual, 2024-03-31) — Share Issued: 54141193.00
SAGE.V income_statement (annual, 2024-03-31) — Special Income Charges: 10873.00
SAGE.V cash_flow (annual, 2024-03-31) — Stock Based Compensation: 229947.00
SAGE.V balance_sheet (annual, 2024-03-31) — Stockholders Equity: 226282.00
SAGE.V balance_sheet (annual, 2024-03-31) — Tangible Book Value: 226282.00
SAGE.V income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
SAGE.V income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
SAGE.V balance_sheet (annual, 2024-03-31) — Taxes Receivable: 23154.00
SAGE.V balance_sheet (annual, 2024-03-31) — Total Assets: 1748696.00
SAGE.V balance_sheet (annual, 2024-03-31) — Total Capitalization: 226282.00
SAGE.V balance_sheet (annual, 2024-03-31) — Total Debt: 54412.00
SAGE.V balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 226282.00
SAGE.V income_statement (annual, 2024-03-31) — Total Expenses: 3922947.00